Abstract

Phospholipase D (PLD) is a membrane protein with a double role: maintenance of the structural integrity of cellular or intracellular membranes and involvement in cell signaling through the product of the catalytic reaction, PA, and through protein–protein interaction with a variety of partners. Cross-talk during PLD signaling occurs with other cancer regulators (Ras, PDGF, TGF and kinases). Elevation of either PLD1 or PLD2 (the two mammalian isoforms of PLD) is able to transform fibroblasts and contribute to cancer progression. Elevated total PLD activity, as well as overexpression, is present in a wide variety of cancers such as gastric, colorectal, renal, stomach, esophagus, lung and breast. PLD provides survival signals and is involved in migration, adhesion and invasion of cancer cells, and all are increased during PLD upregulation or, conversely, they are decreased during PLD loss of function. Even-though the end results of PLD action as relates to downstream signaling mechanisms are still currently being elucidated, invasion, a pre-requisite for metastasis, is directly affected by PLD. This review will introduce the classical mammalian PLD’s, PLD1 and PLD2, followed by the mechanisms of intracellular regulation and a status of current investigation in the crucial involvement of PLD in cancer, mostly through its role in cell migration, invasion and metastasis, that has grown exponentially in the last few years.

Highlights

  • The role of Phospholipase D (PLD) in cancer and tumorigenesis has been studied in detail in the last decade

  • This study suggested PLD2 might be a prognostic indicator in colon cancers (Saito et al, 2007)

  • We have recently demonstrated that PLD2 plays a role in breast cancer invasion and tumorigenesis in vivo (Henkels et al, 2013b)

Read more

Summary

Introduction

The role of Phospholipase D (PLD) in cancer and tumorigenesis has been studied in detail in the last decade. PLD overexpression increases cancer cell invasion and metastasis. PLD2 can be activated in intact cells by a variety of agonists and tyrosine kinases (Foster and Xu, 2003) and can be regulated by small GTPases and certain PKC family members (Du et al, 2000).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call